Axiom Biotechnologies

Axiom Biotechnologies is an emerging biopharmaceutical company focused on rapid discovery. By utilizing our proprietary human cell-based physiological genomics technology, we develop more effective and safer drugs. This technology integrates a human cell library containing over 100 human cell lines representing all major tissues of the human body, as well as its proprietary cell analysis technology. By using human cell lines, Axiom accurately represents gene functions and directly determines their effectiveness as drug targets. Axiom Biotechnologies is currently applying this drug discovery approach through its internal drug discovery programs in the fields of cancer, gastroesophageal reflux disease, and obesity, as well as through strategic collaborations with other pharmaceutical and biotechnology companies.